Back

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe

2 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Novel anticoagulants and indications Anticoagulants ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tim Anthonie Christiaan de Vries

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Factor XI activity in ST-segment elevation myocardial infarction
Doctor M. Spagnolo (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials
Doctor M. Maqsood (Houston, US)
Abstract Slides Video
Presentation thumbnail
Direct Oral Anticoagulants versus Vitamin K Antagonists for the management of left ventricular thrombus after myocardial infarction: A meta-analysis
Doctor C. Gogos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Unfractionated heparin or low molecular weight heparin in patients with acute pulmonary embolism: a meta-analysis of randomized controlled trials
Doctor M. Maqsood (Houston, US)
Abstract Slides Video
Presentation thumbnail
Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Novel anticoagulants and indications

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
AF patients in routine practice: a long-term perspective from ETNA-AF-Europe
thumbnail
Congress Presentation
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study
thumbnail
Congress Session
Cardiovascular treatment: protecting the brain and the limbs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources